Overview

Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics

Status:
Recruiting

Trial end date:
2021-06-10

Target enrollment:
0

Participant gender:
All

Summary

An increasing number of studies have reported the use of dexmedetomidine in clinical practice. However, few studies have reported on the intranasal use of dexmedetomidine in radiological procedures The aim of this work is to compare the efficacy and safety of intranasal dexmedetomidine and intranasal midazolam in pediatrics undergoing MRI.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Tanta University

Treatments:

Dexmedetomidine
Midazolam

Criteria

Inclusion Criteria:

Aged from 2 to 8 years Both sexes ASA physical status I and II Elective MRI.

Exclusion Criteria:

1. Patient's guardian refusal.

2. Body mass index >30 kg/m2

3. Known allergy to dexmedetomidine or midazolam.

4. Suspected difficult airway.

5. Upper respiratory tract infection

6. Anatomical structural deformity of the nasal cavity.

7. Severe liver or renal impairment.

8. Severe bradycardia or atrioventricular block above II degree type 2.

9. Administration of digoxin or beta blockers